Follow
Fernando Gomollon
Title
Cited by
Cited by
Year
The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management
A Dignass, G Van Assche, JO Lindsay, M Lémann, J Söderholm, ...
Journal of Crohn's and Colitis 4 (1), 28-62, 2010
2262*2010
3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management
F Gomollón, A Dignass, V Annese, H Tilg, G Van Assche, JO Lindsay, ...
Journal of Crohn's and Colitis 11 (1), 3-25, 2017
22042017
ECCO guidelines on therapeutics in Crohn's disease: medical treatment
J Torres, S Bonovas, G Doherty, T Kucharzik, JP Gisbert, T Raine, ...
Journal of Crohn's and Colitis 14 (1), 4-22, 2020
11052020
3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 2: surgical management and special situations
P Gionchetti, A Dignass, S Danese, FJ Magro Dias, G Rogler, PL Lakatos, ...
Journal of Crohn's and Colitis 11 (2), 135-149, 2017
7912017
Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and …
A Lanas, LA García-Rodríguez, MT Arroyo, F Gomollón, F Feu, ...
Gut 55 (12), 1731-1738, 2006
7392006
European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases
AU Dignass, C Gasche, D Bettenworth, G Birgegård, S Danese, ...
Journal of Crohn's and Colitis 9 (3), 211-222, 2015
6242015
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases#
C Gasche, A Berstad, R Befrits, C Beglinger, A Dignass, K Erichsen, ...
Inflammatory bowel diseases 13 (12), 1545-1553, 2007
6112007
Randomized Clinical Trial ofPlantago OvataSeeds (Dietary Fiber) As Compared With Mesalamine in Maintaining Remission in Ulcerative Colitis
F Fernandez-Banares, J Hinojosa, JL Sanchez-Lombrana, E Navarro, ...
Official journal of the American College of Gastroenterology| ACG 94 (2 …, 1999
5211999
ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment
M Adamina, S Bonovas, T Raine, A Spinelli, J Warusavitarne, A Armuzzi, ...
Journal of Crohn's and Colitis 14 (2), 155-168, 2020
4672020
Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants
A Lanas, LA García-Rodríguez, MT Arroyo, L Bujanda, F Gomollón, ...
Official journal of the American College of Gastroenterology| ACG 102 (3 …, 2007
3952007
Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients
M Chaparro, I Ordás, E Cabré, V Garcia-Sanchez, G Bastida, M Peñalva, ...
Inflammatory bowel diseases 19 (7), 1404-1410, 2013
3262013
Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review
JP Gisbert, F Gomollón
Official journal of the American College of Gastroenterology| ACG 103 (7 …, 2008
2962008
Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease
JP Gisbert, F Gomollón
Official journal of the American College of Gastroenterology| ACG 103 (5 …, 2008
2922008
Anemia and inflammatory bowel diseases
F Gomollón, JP Gisbert
World journal of gastroenterology: WJG 15 (37), 4659, 2009
2902009
Meta‐analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
JP Gisbert, PM Linares, AG McNicholl, J Maté, F Gomollón
Alimentary pharmacology & therapeutics 30 (2), 126-137, 2009
2822009
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease
MJ Casanova, M Chaparro, E Domenech, M Barreiro-de Acosta, ...
Official journal of the American College of Gastroenterology| ACG 108 (3 …, 2013
2642013
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease
NT Ventham, NA Kennedy, AT Adams, R Kalla, S Heath, KR O'leary, ...
Nature communications 7 (1), 13507, 2016
2282016
ECCO position statement: the use of biosimilar medicines in the treatment of inflammatory bowel disease (IBD)
S Danese, F Gomollon, Governing Board and Operational Board of ECCO
Journal of Crohn's and Colitis 7 (7), 586-589, 2013
2142013
Role of 5-aminosalicylic acid (5-asa) in treatment of inflammatory bowel disease: a systemic review
JP Gisbert, F Gomollón, J Maté, JM Pajares
Digestive diseases and sciences 47, 471-488, 2002
1862002
Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study)
MA Montoro, LJ Brandt, S Santolaria, F Gomollon, BS Puértolas, J Vera, ...
Scandinavian journal of gastroenterology 46 (2), 236-246, 2011
1712011
The system can't perform the operation now. Try again later.
Articles 1–20